Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DermTech, Inc. - Common Stock (NQ:DMTK)

0.0940 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about DermTech, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
DermTech: Q1 Earnings Insights
DermTech (NASDAQ:DMTK) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DermTech missed estimated earnings by... 
Via Benzinga
DermTech's Earnings Outlook
DermTech (NASDAQ:DMTK) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that DermTech will... 
Via Benzinga
DermTech: Q4 Earnings Insights
DermTech (NASDAQ:DMTK) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DermTech... 
Via Benzinga
Earnings Scheduled For March 1, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
Earnings Outlook For DermTech
DermTech (NASDAQ:DMTK) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Indaptus Therapeutics (NASDAQ:INDP 
Via Benzinga
Recap: DermTech Q2 Earnings
Shares of DermTech (NASDAQ:DMTK) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share fell 1.72% over the past year to ($0... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE: 
Via Benzinga
63 Biggest Movers From Friday
Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15... 
Via Benzinga
This Is the Main Problem With DermTech's Q3 Results
Nothing major changed for the skin genomics company in Q3. 
Via The Motley Fool
Better Buy: 10x Genomics vs. DermTech
Both companies offer disruptive new solutions in their niches of the healthcare space. 
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Valneva (NASDAQ:VALN) shares increased by 24.51% to $50.34 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.6... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, trader! It's time to start another busy day of trading with a dive into the biggest pre-market stock movers for Wednesday. 
Via InvestorPlace
30 Stocks Moving in Wednesday's Pre-Market Session
Gainers RenovoRx, Inc. (NASDAQ: RNXT) rose 113% to $11.50 in pre-market trading. The company, on Tuesday evening, made a presentation on intra-arterial chemotherapy as a... 
Via Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:... 
Via Benzinga
Exposures COVID-19
DermTech's Return On Capital Employed Overview
DermTech (NASDAQ:DMTK) brought in sales totaling $3.12 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 29.03%, resulting in a loss of $17... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the... 
Via Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
3 Things About DermTech That Smart Investors Know
These three facts can help you determine whether you want in on this fast-growing company. 
Via The Motley Fool
How DermTech Could Change Skin Cancer Testing -- Or Fizzle Out
DermTech's innovative skin treatment is making it easier and cheaper to test for skin cancer, causing the business to grow. Fast. 
Via The Motley Fool
Should Investors Be Concerned About DermTech?
Be concerned? No. Be patient? Yes. 
Via The Motley Fool
3 Monster Stocks in the Making to Buy Right Now
Their growth prospects are massive. 
Via The Motley Fool
Looking into DermTech's Return on Capital Employed
Pulled from Benzinga Pro data DermTech (NASDAQ:DMTK) reported Q2 sales of $3.12 million. Earnings fell to a loss of $17.31 million, resulting in a 29.03% decrease from last... 
Via Benzinga
Why Shares of DermTech Dropped 19% in July
The company's noninvasive skin genomics platform has great potential, but its losses have made investors wary. 
Via The Motley Fool
99 Biggest Movers From Yesterday
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Scopus BioPharma (NASDAQ:SCPS) s... 
Via Benzinga
This Medical Device Company Is Changing the Game in Skin Cancer
And it's on sale right now. 
Via The Motley Fool
Cramer Weighs In On FireEye, 3D Systems, More
On CNBC's "Mad Money Lightning Round," Jim Cramer revealed he prefers Crowdstrike Holdings Inc (NASDAQ: CRWD), Zscaler Inc (NASDAQ: ZS) and Palo Alto Networks Inc (... 
Via Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.